The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and France
J Med Econ
.
2022 Jan-Dec;25(1):321-323.
doi: 10.1080/13696998.2022.2040255.
Authors
Panagiotis Petrou
1
2
,
Olga Pitsillidou
2
3
,
M J Postma
3
4
Affiliations
1
Pharmacoepidemiology-Pharmacovigilance, Pharmacy School, School of Sciences and Engineering, University of Nicosia, Nicosia, Cyprus.
2
Health Insurance Organization, Nicosia, Cyprus.
3
Department of Health Sciences, Unit of Global Health, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
4
Department of Economics, Econometrics and Finance, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.
PMID:
35137669
DOI:
10.1080/13696998.2022.2040255
No abstract available
Publication types
Editorial
MeSH terms
Biomedical Technology*
France
Germany
Humans
United Kingdom